Time course of changes in bone resorption markers during pamidronate therapy in breast cancer patients with bone metastases
The paper gives the results of evaluating the time course of changes in the level of bone resorption markers (S-CTx and dPir) in pami- dronate-treated patients with bone metastases from breast cancer. It shows the relationship of these markers to clinical and X-ray find- ings. The markers were not f...
Saved in:
Main Authors: | A. D. Petrova (Author), M. B. Stenina (Author), L. V. Manzyuk (Author), N. V. Lyubimova (Author), S. A. Tyulyandin (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2014-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevention of bone metastases in breast cancer
by: L. M. Kogonia
Published: (2014) -
Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density
by: Se Won Lim, et al.
Published: (2016) -
Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases
by: A. S. Kolbin, et al.
Published: (2018) -
Response of Bone Resorption Markers to Aristolochia longa Intake by Algerian Breast Cancer Postmenopausal Women
by: Bachir Benarba, et al.
Published: (2014) -
Effectiveness and safety of pamidronate treatment in nonambulatory children with low bone mineral density
by: Myeongseob Lee, et al.
Published: (2024)